Hypertensive Disorder of Pregnancy Clinical Trial
Official title:
A Remote Postpartum (PP) Blood Pressure Surveillance and Reminder System for Hypertensive Disorders of Pregnancy: A Randomized Clinical Trial
NCT number | NCT03728790 |
Other study ID # | AAAS0065 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 9, 2018 |
Est. completion date | May 11, 2020 |
Verified date | September 2020 |
Source | Columbia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to trial remote patient monitoring (RPM) in the postpartum hypertensive population in a randomized control design, with an aim to increase the number of blood pressure measurements taken during the fragile and under-monitored postpartum period and to thereby improve postpartum blood pressure control and reduce severe morbidity and mortality. The investigators plan to compare the number of blood pressures recorded in the first 10 days postpartum between patients who have been enrolled in an RPM trial to those who are being treated with the usual care.
Status | Completed |
Enrollment | 213 |
Est. completion date | May 11, 2020 |
Est. primary completion date | July 28, 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Postpartum women - Previous diagnosis of chronic hypertension, or antepartum diagnosis of hypertensive disorder of pregnancy (defined as documented blood pressure of =140 systolic or =90 diastolic on at least 2 occasions at least 4 hours apart) - At least 18 years of age - English or Spanish speakers Exclusion Criteria: - Non-English or Spanish speakers - Women who are not planning on obtaining their postpartum follow up at CUIMC - Women who are physically unable to hold or use the tablet - Women who do not have a working phone - Provider unwilling or unable to set up escalation pathway - Women who reside outside of New York State - Hypertension diagnosed postpartum |
Country | Name | City | State |
---|---|---|---|
United States | Columbia University Medical Center | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Columbia University | New York Presbyterian Hospital, Philips Healthcare |
United States,
ACOG Committee Opinion No. 736: Optimizing Postpartum Care. Obstet Gynecol. 2018 May;131(5):e140-e150. doi: 10.1097/AOG.0000000000002633. — View Citation
Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol. 2011 Nov;118(5):1102-7. doi: 10.1097/AOG.0b013e318231934c. — View Citation
Albini F, Xiaoqiu Liu, Torlasco C, Soranna D, Faini A, Ciminaghi R, Celsi A, Benedetti M, Zambon A, di Rienzo M, Parati G. An ICT and mobile health integrated approach to optimize patients' education on hypertension and its management by physicians: The Patients Optimal Strategy of Treatment(POST) pilot study. Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:517-520. doi: 10.1109/EMBC.2016.7590753. — View Citation
American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122-31. doi: 10.1097/01.AOG.0000437382.03963.88. — View Citation
Arnhold M, Quade M, Kirch W. Mobile applications for diabetics: a systematic review and expert-based usability evaluation considering the special requirements of diabetes patients age 50 years or older. J Med Internet Res. 2014 Apr 9;16(4):e104. doi: 10.2196/jmir.2968. Review. — View Citation
Bryant AS, Haas JS, McElrath TF, McCormick MC. Predictors of compliance with the postpartum visit among women living in healthy start project areas. Matern Child Health J. 2006 Nov;10(6):511-6. — View Citation
Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, Howard VJ, Lichtman JH, Lisabeth LD, Piña IL, Reeves MJ, Rexrode KM, Saposnik G, Singh V, Towfighi A, Vaccarino V, Walters MR; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council for High Blood Pressure Research. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 May;45(5):1545-88. doi: 10.1161/01.str.0000442009.06663.48. Epub 2014 Feb 6. Review. Erratum in: Stroke. 2014 Oct;45(10);e214. Stroke.2014 May;45(5):e95. — View Citation
Clapp MA, Little SE, Zheng J, Robinson JN. A multi-state analysis of postpartum readmissions in the United States. Am J Obstet Gynecol. 2016 Jul;215(1):113.e1-113.e10. doi: 10.1016/j.ajog.2016.01.174. — View Citation
Clark SL, Belfort MA, Dildy GA, Englebright J, Meints L, Meyers JA, Frye DK, Perlin JA. Emergency department use during the postpartum period: implications for current management of the puerperium. Am J Obstet Gynecol. 2010 Jul;203(1):38.e1-6. doi: 10.1016/j.ajog.2010.02.033. Epub 2010 Apr 24. — View Citation
Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol. 2015 Jan;125(1):5-12. doi: 10.1097/AOG.0000000000000564. — View Citation
Gandapur Y, Kianoush S, Kelli HM, Misra S, Urrea B, Blaha MJ, Graham G, Marvel FA, Martin SS. The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review. Eur Heart J Qual Care Clin Outcomes. 2016 Oct 1;2(4):237-244. doi: 10.1093/ehjqcco/qcw018. Review. — View Citation
Goel A, Maski MR, Bajracharya S, Wenger JB, Zhang D, Salahuddin S, Shahul SS, Thadhani R, Seely EW, Karumanchi SA, Rana S. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period. Circulation. 2015 Nov 3;132(18):1726-33. doi: 10.1161/CIRCULATIONAHA.115.015721. Epub 2015 Sep 28. — View Citation
Hirshberg A, Downes K, Srinivas S. Comparing standard office-based follow-up with text-based remote monitoring in the management of postpartum hypertension: a randomised clinical trial. BMJ Qual Saf. 2018 Nov;27(11):871-877. doi: 10.1136/bmjqs-2018-007837. Epub 2018 Apr 27. — View Citation
Levine LD, Nkonde-Price C, Limaye M, Srinivas SK. Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia. J Perinatol. 2016 Dec;36(12):1079-1082. doi: 10.1038/jp.2016.137. Epub 2016 Sep 1. — View Citation
Rhoads SJ, Serrano CI, Lynch CE, Ounpraseuth ST, Gauss CH, Payakachat N, Lowery CL, Eswaran H. Exploring Implementation of m-Health Monitoring in Postpartum Women with Hypertension. Telemed J E Health. 2017 Oct;23(10):833-841. doi: 10.1089/tmj.2016.0272. Epub 2017 May 5. — View Citation
Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol. 2012 Jun;206(6):470-5. doi: 10.1016/j.ajog.2011.09.002. Epub 2011 Sep 16. Review. — View Citation
Too G, Wen T, Boehme AK, Miller EC, Leffert LR, Attenello FJ, Mack WJ, D'Alton ME, Friedman AM. Timing and Risk Factors of Postpartum Stroke. Obstet Gynecol. 2018 Jan;131(1):70-78. doi: 10.1097/AOG.0000000000002372. — View Citation
Tully KP, Stuebe AM, Verbiest SB. The fourth trimester: a critical transition period with unmet maternal health needs. Am J Obstet Gynecol. 2017 Jul;217(1):37-41. doi: 10.1016/j.ajog.2017.03.032. Epub 2017 Apr 5. — View Citation
Walters BN, Thompson ME, Lee A, de Swiet M. Blood pressure in the puerperium. Clin Sci (Lond). 1986 Nov;71(5):589-94. — View Citation
Wenger NK, Arnold A, Bairey Merz CN, Cooper-DeHoff RM, Ferdinand KC, Fleg JL, Gulati M, Isiadinso I, Itchhaporia D, Light-McGroary K, Lindley KJ, Mieres JH, Rosser ML, Saade GR, Walsh MN, Pepine CJ. Hypertension Across a Woman's Life Cycle. J Am Coll Cardiol. 2018 Apr 24;71(16):1797-1813. doi: 10.1016/j.jacc.2018.02.033. Review. — View Citation
* Note: There are 20 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood Pressure (BP) Surveillance Adherence | Percentage of recommended twice-daily blood pressures reported between hospital discharge and first outpatient blood pressure assessment | Up to 14 days from delivery hospitalization discharge | |
Secondary | Elevated Blood Pressure Percentage | Percentage of recorded blood pressure values at first outpatient blood pressure assessment that are elevated (>140 systolic or >90 diastolic) | Up to 14 days from delivery hospitalization discharge | |
Secondary | Number of Participants With Outpatient BP Assessment Within 14 Days | Number of participants who had a documented outpatient BP assessment within 14 days of hospital discharge | Up to 14 days from delivery hospitalization discharge | |
Secondary | Incidence of BP Elevations | Incidence of elevated blood pressure at outpatient blood pressure assessment | Up to 14 days from delivery hospitalization discharge | |
Secondary | Number of Participants With Outpatient PP Assessment | Number of participants who had an outpatient postpartum (PP) assessment | Up to 8 weeks from delivery | |
Secondary | Incidence of BP Elevations | Incidence of elevated blood pressure (BP) at the postpartum visit | Up to 8 weeks from delivery | |
Secondary | Time to Medication Initiation | Time to initiation of antihypertensive medications (in patients who were not on medications at time of discharge) | Up to 8 weeks from delivery | |
Secondary | Number of Participants Initiated on Antihypertensive Therapy After Hospital Discharge | Number of participants discharged from delivery hospitalization without antihypertensive therapy, who were subsequently started on antihypertensive therapy | Up to 8 weeks from delivery | |
Secondary | Number of Participants Readmitted | Number of participants who were readmitted after delivery hospitalization discharge | Up to 8 weeks from delivery | |
Secondary | Number of Participants With ED Visit | Number of participants who had an Emergency Department (ED) visit after delivery hospitalization discharge | Up to 8 weeks from delivery | |
Secondary | Number of Participants Who Developed Preeclampsia-associated Complications | Number of patients who experienced preeclampsia-related morbidity (eg: stroke, seizure, posterior reversible encephalopathy syndrome (PRES) , pulmonary edema, liver function abnormality, reversible cerebral vasoconstriction syndrome (RCVS) , renal insufficiency, thrombocytopenia) after delivery hospitalization discharge. | Up to 8 weeks from delivery | |
Secondary | Number of Participants Referred to Primary Care for Continued Blood Pressure Management | Number of participants who require a referral to primary care physicians for continued blood pressure management after being discharged from obstetric care at the postpartum visit | Up to 8 weeks from delivery | |
Secondary | Score on the Modified Telemedicine Satisfaction and Usefulness Questionnaire (TSUQ) | The modified TSUQ is an 18-item survey that will be used to measure patient satisfaction with remote blood pressure monitoring. Individuals score each of the items based on their satisfaction, with 1=strongly disagree to 5=strongly agree. The responses would then be used to calculate a mean score on the 5-point scale, with 5 indicating the most satisfaction. | Up to 8 weeks from delivery | |
Secondary | Change in Score on the Philips Program Survey | The Philips program start survey is a 4 question survey to gauge how patients relate to their care and their doctors prior to initiation of their blood pressure monitoring program. Individuals score each of the items based on the perception of their care, with 5 being best and 1 being worst. The responses would then be used to calculate a mean score on the 5-point scale, with 5 indicating the most satisfaction, and compared between the 2 groups. The Philips program end survey is a 6 question survey to gauge how patients related to their care and their doctors after the completion of their blood pressure monitoring program. Individuals score each of the items based on the perception of their care, with 5 being best and 1 being worst. The responses would then be used to calculate a mean score on the 5-point scale, with 5 indicating the most satisfaction, and compared between the 2 groups. | Up to 8 weeks from delivery | |
Secondary | Communications | Elevated blood pressures that led to communication with an obstetric provider | Up to 14 days post delivery hospitalization discharge |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05999851 -
Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy
|
N/A | |
Recruiting |
NCT05687344 -
Intensive Postpartum Antihypertensive Treatment
|
Phase 3 | |
Recruiting |
NCT06377878 -
The Preeclampsia Registry
|
||
Recruiting |
NCT02020174 -
The Preeclampsia Registry
|
||
Recruiting |
NCT05995106 -
mHealth for Hypertensive Disorder of Pregnancy
|
N/A | |
Completed |
NCT03309826 -
Positive Airway Pressure Treatment of Obstructive Sleep-disordered Breathing in Hypertensive Disorders of Pregnancy
|
N/A | |
Completed |
NCT05631067 -
Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and Mortality
|
N/A | |
Completed |
NCT03412552 -
Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia
|
N/A | |
Recruiting |
NCT05089175 -
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
|
||
Enrolling by invitation |
NCT05763069 -
HOME: Home Monitoring of High-risk Pregnancies
|
||
Recruiting |
NCT06069102 -
Optimal Blood Pressure Treatment Thresholds Postpartum
|
Phase 4 | |
Recruiting |
NCT05659173 -
Vitamin D Deficiency With Selected Vitamin D Receptor Gene Polymorphism in Gestational Hypertension
|
||
Recruiting |
NCT06281665 -
Treatment With Aspirin After Preeclampsia: TAP Trial
|
Phase 4 | |
Completed |
NCT05124327 -
Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy
|
N/A | |
Recruiting |
NCT06362356 -
Microbial Metabolites and Outcomes of Pregnancy Study
|
||
Active, not recruiting |
NCT04580927 -
Breastfeeding and Postpartum Cardiovascular Health
|
N/A | |
Recruiting |
NCT05655936 -
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
|
N/A | |
Enrolling by invitation |
NCT05835596 -
MumCare: Mum's Cardiovascular Health for Life
|
N/A | |
Completed |
NCT06019715 -
Remote Postpartum Intervention Targeting Movement Behaviors After Hypertensive Disorders of Pregnancy
|
N/A | |
Not yet recruiting |
NCT06220721 -
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
|
Phase 3 |